Total Payments
$9,319
2024 Payments
$505.97
Companies
38
Transactions
646
Medicare Patients
560
Medicare Billing
$60,247
Payment Breakdown by Category
Food & Beverage$9,266 (99.4%)
Education$53.75 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,266 | 630 | 99.4% |
| Education | $53.75 | 16 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,980 | 154 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,628 | 81 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $866.34 | 71 | $0 (2024) |
| Merck Sharp & Dohme LLC | $684.98 | 50 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $601.27 | 44 | $0 (2023) |
| Lilly USA, LLC | $555.36 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $385.74 | 22 | $0 (2018) |
| Amgen Inc. | $343.05 | 27 | $0 (2024) |
| GlaxoSmithKline, LLC. | $341.56 | 23 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $269.73 | 20 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $505.97 | 29 | Novo Nordisk Inc ($151.96) |
| 2023 | $722.47 | 46 | Novo Nordisk Inc ($263.75) |
| 2022 | $955.35 | 68 | Novo Nordisk Inc ($352.06) |
| 2021 | $969.71 | 72 | Novo Nordisk Inc ($316.61) |
| 2020 | $1,137 | 83 | Novo Nordisk Inc ($220.09) |
| 2019 | $1,152 | 89 | Novo Nordisk Inc ($221.40) |
| 2018 | $983.16 | 81 | AstraZeneca Pharmaceuticals LP ($277.12) |
| 2017 | $2,894 | 178 | AstraZeneca Pharmaceuticals LP ($760.57) |
All Payment Transactions
646 individual payment records from CMS Open Payments — Page 2 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Diabetes | ||||||
| 02/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Diabetes | ||||||
| 01/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/15/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.42 | General |
| 11/09/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Diabetes | ||||||
| 10/24/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Diabetes | ||||||
| 10/19/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: VACCINES | ||||||
| 10/17/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Diabetes | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Diabetes | ||||||
| 08/23/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.70 | General |
| 08/10/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Diabetes | ||||||
| 08/04/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Diabetes | ||||||
| 07/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: RESPIRATORY | ||||||
| 07/07/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/26/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: RESPIRATORY | ||||||
| 06/23/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: RESPIRATORY | ||||||
| 06/22/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Diabetes | ||||||
| 06/21/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.37 | General |
| 06/12/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug), LIVALO | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 132 | 217 | $69,070 | $13,826 |
| 2022 | 5 | 135 | 278 | $68,510 | $13,702 |
| 2021 | 4 | 143 | 309 | $66,125 | $16,573 |
| 2020 | 5 | 150 | 335 | $72,025 | $16,146 |
Total Patients
560
Total Services
1,139
Medicare Billing
$60,247
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 103 | $40,902 | $6,502 | 15.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $17,024 | $4,229 | 24.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $7,927 | $1,991 | 25.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 38 | 59 | $708.00 | $495.60 | 70.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $1,236 | $407.64 | 33.0% |
| 90471 | Administration of vaccine | Office | 2023 | 12 | 14 | $1,273 | $200.97 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 145 | $48,600 | $8,811 | 18.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 26 | $10,419 | $2,568 | 24.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 13 | 13 | $5,225 | $1,904 | 36.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 45 | 80 | $3,202 | $237.00 | 7.4% |
| 90471 | Administration of vaccine | Office | 2022 | 14 | 14 | $1,064 | $182.28 | 17.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 112 | $36,400 | $9,903 | 27.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 81 | $24,325 | $6,338 | 26.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 49 | 100 | $5,000 | $297.00 | 5.9% |
| 81003 | Automated urinalysis test | Office | 2021 | 12 | 16 | $400.00 | $36.00 | 9.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 57 | 177 | $57,525 | $14,253 | 24.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 28 | $8,400 | $1,048 | 12.5% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2020 | 11 | 11 | $500.01 | $500.01 | 100.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 52 | 105 | $5,250 | $312.90 | 6.0% |
| 81003 | Automated urinalysis test | Office | 2020 | 12 | 14 | $350.00 | $31.20 | 8.9% |
About Dr. Thomas Francis, D.O
Dr. Thomas Francis, D.O is a Internal Medicine healthcare provider based in Kearny, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1497894091.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Francis, D.O has received a total of $9,319 in payments from pharmaceutical and medical device companies, with $505.97 received in 2024. These payments were reported across 646 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($9,266).
As a Medicare-enrolled provider, Francis has provided services to 560 Medicare beneficiaries, totaling 1,139 services with total Medicare billing of $60,247. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics
- Location Kearny, NJ
- Active Since 02/06/2007
- Last Updated 09/06/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497894091
Products in Payments
- FARXIGA (Drug) $1,164
- Ozempic (Drug) $1,003
- JARDIANCE (Drug) $705.05
- ENTRESTO (Drug) $544.46
- Rybelsus (Drug) $448.67
- VERQUVO (Drug) $277.77
- TRULICITY (Drug) $275.25
- INVOKANA (Drug) $266.98
- JANUVIA (Drug) $248.64
- SYMBICORT (Drug) $243.86
- Livalo (Drug) $240.64
- Victoza (Drug) $194.10
- SOLIQUA 100/33 (Biological) $175.31
- Repatha (Biological) $162.30
- TRELEGY ELLIPTA (Drug) $160.44
- ANORO (Drug) $141.36
- Saxenda (Drug) $141.02
- NUZYRA (Drug) $114.99
- UBRELVY (Drug) $111.95
- Aimovig (Biological) $108.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kearny
Jehad Saliba, Md, MD
Internal Medicine — Payments: $26,548
Internal Medicine $26,548
Gary Cardiello, Md, MD
Internal Medicine — Payments: $12,383
Internal Medicine $12,383
Dr. Richard Romano, Do, Dc, DO, DC
Internal Medicine — Payments: $619.58
Internal Medicine $619.58
Prakash Doshi, M.d, M.D
Internal Medicine — Payments: $601.50
Internal Medicine $601.50
Dr. Mudassar Sharif, M.d, M.D
Internal Medicine
Internal Medicine
Salvatore Rifici, Md, MD
Internal Medicine
Internal Medicine